<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain><z:hpo ids='HP_0012133'>Erythroid hypoplasia</z:hpo> in <z:hpo ids='HP_0002863'>myelodysplastic syndrome</z:hpo> (<z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">MDS</z:e>) happens to be a rare association and is being recognized as a distinct clinico pathological entity </plain></SENT>
<SENT sid="1" pm="."><plain>We report here two such cases diagnosed as Refractory <z:hpo ids='HP_0001903'>anaemia</z:hpo> (RA) and Refractory <z:hpo ids='HP_0001903'>anaemia</z:hpo> with excess blast (<z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">RAEB</z:e>) who had marked suppression of the erythroid cell lines </plain></SENT>
<SENT sid="2" pm="."><plain>Both patients presented with severe transfusion dependent <z:hpo ids='HP_0001903'>anaemia</z:hpo> </plain></SENT>
<SENT sid="3" pm="."><plain>Recognition of these cases is important as alternative modalities of treatment such as immunosuppressives may be considered for these patients </plain></SENT>
</text></document>